RWJBarnabas institute awarded $3.75M for opioid recovery services

West Orange, N.J.-based RWJBarnabas’ Institute for Prevention and Recovery has been gifted $3.75 million from the Substance Abuse and Mental Health Services Administration for opioid use disorder medication access.

Advertisement

Over the next five years, the funding will be used to create the Medication-Assisted Treatment — Prescription Drug and Opioid Addiction program and build bridge clinics at Newark (N.J.) Beth Israel Medical Center and Belleville, N.J.-based Clara Maass Medical Center. 

“We are thrilled to be awarded this grant funding which will enable us to establish a bridge clinic, increasing access to medication for opioid use disorder and enhancing our ability to encourage patients to enter and remain in treatment,” Connie Greene, senior vice president for RWJBarnabas Health Institute for Prevention and Recovery, said in a Sept. 24 news release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.